Evidence based recommendation for anticoagulation in children with congenital heart disease (Primary prophylaxis: Cardiac catheterization, mechanical heart valves, cardiac shunts, central lines and Secondary prophylaxis: Systemic thrombosis and stroke)

Progress in Pediatric Cardiology

Volumn 21, Issue 1, 2005, Pages 123-127

  Patricia Massicotte, M ^a   Olley Chair, Peter ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K; ASPARAGINASE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLASMINOGEN;

ANTICOAGULANT THERAPY; ANTICOAGULATION; BLEEDING; CLINICAL TRIAL; CONGENITAL HEART DISEASE; DEEP VEIN THROMBOSIS; FIBRINOLYTIC THERAPY; HEART CATHETERIZATION; HEART SEPTUM DEFECT; HEART VALVE; HEPARINIZATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; KIDNEY VEIN THROMBOSIS; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENT DISEASE; REVIEW; RISK FACTOR; STROKE; THROMBOSIS; UREMIA; VENOUS THROMBOEMBOLISM;

EID: 28844472495     PISSN: 10589813     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ppedcard.2005.09.013     Document Type: Article

References (1)

1. D. Salem, P. Stein, and A. Al-Ahmad Antithrombotic therapy in valvular heart disease-native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Theraphy CHEST 126 2004 457S 482S